Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
2,451,254
-
Shares change
-
+291,560
-
Total reported value, excl. options
-
$344,547
-
Value change
-
+$40,100
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$0.1402
Significant Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q2 2023
10 filings reported holding JSPRW - Jasper Therapeutics, Inc. - *W EXP 09/24/202 as of Q2 2023.
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,451,254 shares
.
Largest 10 shareholders include COWEN AND COMPANY, LLC (782,341 shares), Walleye Capital LLC (700,737 shares), Ionic Capital Management LLC (443,211 shares), TENOR CAPITAL MANAGEMENT Co., L.P. (250,000 shares), CSS LLC/IL (81,957 shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (79,771 shares), ZAZOVE ASSOCIATES LLC (65,456 shares), EQUITEC PROPRIETARY MARKETS, LLC (33,586 shares), Walleye Trading LLC (14,095 shares), and MORGAN STANLEY (100 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.